The Effectiveness and Safety of Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer Patients With Stage III/IV: A Multicenter Study.
Hsu JC, Nguyen PA, Chen YT, Yang SC, Lin CC, Yang YH, Lin YC, Hsia TC, Hsieh HC, Wu JS, Chang CP, Feng YH, Lin PC, Hsu PC, Tzeng HE, Chien SC, Chang WC, Chang CC, Yang HC, Lee CM, Lu CY.
Hsu JC, et al. Among authors: hsieh hc.
Front Oncol. 2021 Jul 7;11:671127. doi: 10.3389/fonc.2021.671127. eCollection 2021.
Front Oncol. 2021.
PMID: 34307141
Free PMC article.